5 completed. 5 Not applicable.
By phase and status
Follow Bioequivalance: new trials by email Literature Review of Bioequivalance trials Research Report on Bioequivalance
Trials (filtered) newest first · largest first
All 5 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
Clinical Study to Determine Bioequivalence of Oral Tamsulosin Products as 0.4 mg Prolonged-release Tablets in Male Subjects Under Fasted Conditions TAMSULOSIN TEST, OMNIC OCAS REFERENCE - Bioequivalance | Not applicable | Completed | 34 | 2026-01-12 | 2026-07-13 |
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects, Fed Study. Janumet XR, Sitagliptin/Metformin FDC - Bioequivalance | Not applicable | Completed | 46 | 2025-12-08 | 2026-08-14 |
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects, Fast Study. Janumet XR, Sitagliptin/Metformin FDC - Bioequivalance | Not applicable | Completed | 46 | 2025-12-03 | 2026-08-14 |
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fast Study. Sitagliptin/Metformin FDC, Janumet XR - Bioequivalance | Not applicable | Completed | 46 | 2025-11-19 | 2026-08-14 |
Bioequivalence Study of EMPAGLIFLOZIN (25 mg Tablets) vs. JARDIANCE® (25 mg Tablets), in Healthy Research Subjects, Under Fasting Conditions Empagliflozin (Jardiance®), Empagliflozin (oral) - Bioequivalance | Not applicable | Completed | 32 | 2024-11-29 | 2026-03-18 |
Interventions
Sitagliptin Phosphate (3) · Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination (3) · Metformin (2) · empagliflozin (1)
Sponsors
ADIUM (5)
Countries
Mexico (5)
Results publications
PMID 42654125